International Society for Hemodialysis™ (ISHD)
Hemodialysis UniversityŽ


October 2 - 3, 2015, Chicago, Illinois USA
     HDCN key zone registration or ISHD membership-at-large is required.
  Part 4. Rationale Of Progressive Start, And Update On KDOQI Adequacy Guidelines
Progressive Start: Evidence And Rationale
John T. Daugirdas, MD
Progressive Start and Its Impact On Residual Renal Function
Kam Kalantar-Zadeh, MD
Panel Discussion
Drs. Daugirdas, and Kalantar-Zadeh
KDOQI Adequacy Guidelines Update
Thomas Depner, MD
Panel Discussion
Drs. Daugirdas, Kalantar-Zadeh, and Depner

John T. Daugirdas, MD (Course Director)
Clinical Professor of Medicine
University of Illinois at Chicago School of Medicine
Chicago, Illinois. USA

Tom A. Depner, MD
Professor of Internal Medicine and Nephrology
University of California, Davis
Lawrence J. Ellison Ambulatory Care Center
Nephrology Clinic
Sacramento, California

Kam Kalantar-Zadeh, MD,
Chief, Division of Nephrology & Hypertension
Professor of Medicine, Pediatrics and Public Health
University of California, Irvine
Adjunct Professor of Epidemiology
UCLA Fielding School of Public Health
Orange, California
This educational activity is an audio recording with accompanying slides of a live presentation held on October 2 - 3, 2015, in Chicago, Illinois, USA. Continuing medical education credit is not available for this on-line archive. To view this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from www.adobe.com) is useful but not necessary to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the slide handouts.

Program Overview
Target Audience
The conference is designed for health professionals involved in dialysis programs, primarily nephrologists, nephrology fellows, nephrology nurses and nurse practitioners, and patient care technicians.

SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE:
Disclosure Policy
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.

Off-label/lnvestigational Use
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.
POLICY STATEMENTS:


The policy statements of HDCN are listed on this page.